HTG Molecular Diagnostics, The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) deal

HTG and PROOF partnered to develop an RNA-based liquid biopsy from peripheral blood using HTG’s EdgeSeq technology to provide early indication of organ rejection in heart transplant patients. HTG said...